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The effects of cyclosporin A (CsA), a potent immunosuppressive drug with anti-
parasitic activity, on the innate immunological response in guinea pig lungs during an
early period (6th and 14th days) after T. spiralis infection were studied. CsA treat-
ment of T. spiralis-infected guinea pigs caused a significant attenuation of immuno-
logical response in lungs by decreasing lymphocyte infiltration into pulmonary alveo-
lar space, inhibiting alveolar macrophage superoxide anion production and lowering
both the production of NO metabolites measured in bronchoalveolar lavage fluid and
expression of the iNOS protein in lung homogenates, allowing us to speculate that the
T. spiralis-dependent immunological response is dependent on lymphocyte T func-
tion. Interestingly, CsA itself had a pro-inflammatory effect, promoting leucocyte ac-
cumulationandmacrophagesuperoxideproductioninguineapiglungs.Thisobserva-
tion may have a relevance to the situation in patients undergoing CsA therapy.
Macrophage expression of the iNOS protein, evaluated by immunoblotting was not in-
fluenced by treatment of animals with CsA or anti-TGF-antibody, indicating different
regulation of the guinea pig and murine enzymes.
Trichinellosis is a serious disease caused by
the parasitic nematode Trichinella spiralis. It
invades man and other mammals and causes
pathologicalchangesinvarioustissuesinclud-
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worms (developing from infective larvae) oc-
curs in the epithelium of the host’s small in-
testine. The fertilized females enter the intes-
tinal wall and release newborn larvae to the
bloodstream (Despommier, 1993). These, pen-
etrating host’s skeletal muscles, pass on their
way the liver and lung microvascular systems
(Wang & Bell, 1986). Larval cuticular frag-
ments, found in the lungs of T. spiralis-in-
fected rats (Bruschi et al., 1992), may act as
antigens stimulating both specific and non-
specific defense reactions during the so called
“lung phase” of infection. Gastrointestinal
nematode infections are known to be con-
trolled by T-cell mechanisms of immunity
(Miller, 1984) via the release of lymphokines,
generating acute inflammatory response (Bo-
las-Fernandez et al., 1988). Granulocytes and
macrophageshavebeenshowninvivotobein-
volved in killing newborn larvae by anti-
body-dependent cytotoxic mechanisms (Bell,
1998).
The fungal cyclic undecapeptide cyclosporin
A (CsA) is a potent immunosuppressive agent
causing a specific and reversible inhibition of
T helper lymphocyte activation and function.
CsA inhibits production of cytokines (IL-2,
IL-6, IFN-) by T helper lymphocytes stimu-
lated through the T cell antigen receptor path-
way (Colombani & Hess, 1987; Bunjes et al.,
1981). This results in an indirect inhibitory ef-
fect on growth and differentiation of B lym-
phocytes and other antigen-presenting cells.
Indirect inhibitory effects of CsA on masto-
cytes, eosinophils and natural killer cells have
been also described (Thomson, 1992). Numer-
ous studies revealed macrophage functions,
e.g. phagocytic activity, chemotactic migra-
tion, superoxide and peroxide production and
protein secretion, to be unchanged or reduced
in the presence of CsA (Losa Garcia et al.,
1998; Svenson et al., 1995; reviewed by
Thomson, 1992). Inhibitory effects of CsA on
nitric oxide production in macrophages have
alsobeenreported(Condeetal.,1995;Hattori
& Nakanishi, 1995).
In addition to the complex immunomodu-
latory action, CsA was also found to exert po-
tent anti-parasitic effects, observed during in-
fections by both protozoan and metazoan par-
asites (Chappel & Wastling, 1992). Since
cyclosporin A is both antiparasitic and
immunomodulatory, its clinical use in the
management of organ transplantation has im-
plications for opportunistic parasitic infec-
tions in postoperative patients (Chappel &
Wastling, 1992).
Pulmonary alveolar macrophages, together
withneutrophils,formthefirstlineoflungde-
fenceagainstpathogens.Nonspecificimmune
response involves production of reactive me-
tabolites of oxygen and nitrogen by macro-
phages of many species, originating from the
activities of the NADPH oxidase complex and
inducible nitric oxide synthase (iNOS, EC
1.14.13.39; induced by macrophage-antigen
contacts), respectively (Morel et al., 1991;
Oswald et al., 1994). Regulation of iNOS ex-
pression is under control of two cytokines:
IFN-beingactivatory,andTGF-beinginhib-
itory (Iyengar et al., 1987; Nathan & Xie;
1994;Vodovotzetal.,1996).Superoxideanion
and nitric oxide, as well as their metabolites,
are highly toxic for most pathogens, including
parasitic nematodes (James, 1995; Miller &
Britigan, 1997), but little is known about their
role in the defence against T. spiralis infec-
tion.
OurearlierstudiesshowedthatT.spiralisin-
fection evokes a response in the lungs of
guinea-pigs during an early period (4–14 days
after infection), manifested by an increase of
cellular infiltration of alveolar space and tran-
sient activation of superoxide production by
cultured alveolar macrophages (Dzik et al.,
2000). The present study was aimed at exam-
iningtheeffectsofCsAontheinnateimmuno-
logical response in guinea pig lungs following
T . spiralis infection, on 6th and 14th days af-
ter infection, i.e. at the time of possible conse-
quences of the passage of newborn larvae
through the vascular bed of lungs (5–6th days
after infection, cf. Bruschi et al., 1992) were
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followed on cellular infiltration into pulmo-
nary alveolar space, production of superoxide
anion and nitric oxide (the latter resulting
from NOS activity) by cultured alveolar
macrophagesandaccumulationofnitricoxide
metabolites (nitrites and nitrates) in
bronchoalveolar lavage fluid (BALF) and lung
tissue. In addition, expression of iNOS was
evaluated by immunobloting in macrophages
obtained from animals infected with
T. spiralis and treated with CsA or anti-TGF-
antibody.
MATERIALS AND METHODS
Reagents.RPMI-1640,DMEM(withoutphe-
nol red), Hank’s balanced salt solution
(HBSS), phosphate-buffered saline (PBS), fe-
tal bovine serum (FBS), Aspergillus sp. nitrate
reductase, catalase, ferricytochrome c, Esche-
richia coli lipopolysaccharide (LPS),
anti-TGF- antibodies and cyclosporin A were
from Sigma (St. Louis, MO, U.S.A.).
[14C]Arginine was from Amersham. Mono-
clonal antibodies (IgG1) against iNOS were
from Transduction Laboratories, and mono-
clonal antibodies against nitrotyrosine were
from Upstate Biotechnology. Amplified
OPTI-4CN kit was from Bio-Rad.
Animal treatment. Guinea pigs tricolor
(250–350g),bothsexes,werepurchasedfrom
afarminZamienie(Poland).Allexperimental
procedures were according to the guidelines
of and approved by the Animal Care Commit-
tee at the Stefañski Institute of Parasitology
of the Polish Academy of Sciences.
Trichinellaspiralis:maintenanceandin-
fection. Parasites were maintained and infec-
tive larvae isolated as previously described
(D¹browska et al., 1996). Guinea pigs were in-
fectedperoswith4000larvae/animal(Lindor
et al., 1983) and kept under standard condi-
tions. Bronchoalveolar lavage (BAL) was per-
formed on 6th and 14th days after infection.
Uninfected guinea pigs served as controls.
CsAtreatment.Thedrug(20mg/kgofbody
weight) in olive oil was given (per os)i n6
doses: 48 and 24 h before infection with T.
spiralisand24,48,72and96hafterinfection.
Animals treated only with CsA obtained pla-
cebo on the day of infection of the animals
with T. spiralis. BAL was performed in all in-
vestigated groups on the 6th and 14th days af-
ter infection with T. spiralis larvae or intro-
duction of placebo.
BCG treatment. In the BCG-treated group,
each animal was given (i.p.) the suspension,
containing 1.5  106 viable lyophilized Myco-
bacterium bovis bacilli (BCG vaccine from Se-
rumandVaccineInstitute,Lublin,Poland),in
a single dose and BAL was performed after 10
days.
Anti-TGF- antibody treatment. Polyclonal
antibodiesagainstTGF-(0.375mgin0.5mlof
0.9% NaCl) were injected twice on the 3th and
5th days after T. spiralis infection into vena
femoralis of anaesthetized guinea pigs.
Paralelly, T. spiralis-infected animals, used as
controls, were injected with 0.9% NaCl. BAL
was performed on the 6th day after infection.
Bronchoalveolar lavage (BAL). Each ani-
mal was anaesthetized with sodium pento-
barbital (Nembutal, 75 mg/kg body weight
i.p.). After intratracheal intubation BAL was
performed by introducing and aspirating PBS
(three 6-ml allotments). The combined BALF
was centrifuged (400  g, 5 min). The cell pel-
let was suspended in PBS, cell number and vi-
ability (always > 90%) were determined,
smears were prepared and the remaining ma-
terialwastakenformacrophageisolation.Dif-
ferential cell counts were performed (under a
light microscope) after staining of smears
with May-Grünwald-Giemsa stain (with 500
cells counted).
Lung samples. Following BAL, lungs were
perfused with PBS, dissected and homoge-
nized(inanicebath)with0.15MKClcontain-
ing 1 mM phenylmethylsulfonyl fluoride
(PMSF) and 1 g/ml leupeptin. Homogenates
were centrifuged at 20000  g for 20 min at
4C.
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macrophages. BALF cells were plated (2–4
 106 cells per dish) in HBSS and alveolar
macrophages isolated by the selective adher-
ence to Petri dish. After 2 h incubation (37C,
5% CO2) HBSS medium was changed for
RPMI-1640 or DMEM (without phenol red)
containing 10% FBS and the adherent macro-
phages (always > 85% pure and > 95% viable)
were incubated for 18 h with or without addi-
tions as indicated.
Superoxide anion (O2
 ) formation. Assays
wereperformedinmacrophageswashedtwice
with 0.9% NaCl. Production of O2
 was deter-
mined based on superoxide dismutase-in-
hibited reduction of ferricytochrome c
(Yamashita et al., 1985). Briefly, following in-
cubation of macrophages in HBSS containing
80 M ferricytochrome c and 20 g/ml
catalase, with or without superoxide dis-
mutase (20 g/ml), samples were withdrawn
at 0, 15, 30, 45 and 60 min and absorbance
was measured at 550 nm ( = 21000 M–1
cm–1).
Cell lysates. Cultured macrophages were
placed on ice and lysed with 200 l of ice-cold
lysis buffer containing 50 mM Tris-buffered
saline, pH 8, 10% glycerol, 1% Triton X-100, 5
mM PMSF, leupeptin and pepstatin (each
2 g/ml), and 1 mM dithiothreitol (DTT).
Lysates were centrifuged (9000  g,4 C, 5
min) and supernatants stored at –20C until
assayed for NOS activity and protein expres-
sion.
Nitric oxide synthase activity. The assay
was based on [14C]citrulline production from
[14C]arginine(Xia&Bredt,1998).Briefly,cell
lysates (25 l) were added to a reaction mix-
ture containing 25 mM Tris/HCl, pH 7.5,
100 M[ 14C]arginine, 3 M tetrahydro-
biopterin, 1 M FAD, 1 M FMN and 1 mM
NADPH. Nonenzymatic controls were run ei-
ther in the absence of NADPH or in the pres-
ence of 1 mM N-nitro-L-arginine methyl es-
ter (L-NAME) in the reaction mixture. The re-
action was terminated after 15 min incuba-
tion at 37C by addition of 4 ml of Hepes, pH
5.5, containing 5 mM EDTA. The resulting so-
lution was applied into 0.6 ml bed volume of
Dowex 50  8–400 Na+ form and followed by
additional 4 ml of the Hepes/EDTA buffer.
Theflow-throughwascollectedina20mlscin-
tillationvialcontaining16mlofBioCarescin-
tillation cocktail and its radioactivity was
measured.
Nitrite (NO2
 ) and nitrate (NO3
 ) measure-
ments. NO2
 was measured in BALF super-
natants or lung homogenates after reduction
to NO2
 by nitrate reductase (from Aspergillus
sp.) in the presence of NADPH. Excess of
NADPH was removed by addition of lactate
dehydrogenase and pyruvate (Gilliam et al.,
1993). Parallely, the recovery of sodium ni-
trate standard was evaluated. NO2
 was as-
sayedwithGriessreagent(Greenetal.,1982).
Briefly, 100 l sample was deproteinized with
30 l of 0.5 M NaOH and 20 l of 0.4 M
ZnSO4, and centrifuged. After addition of
Griess reagent (1% sulfanilamide in 2.5%
phosphoric acid and 0.1% naphtylethylene-
diamide-HCl), followed by 10 min incubation,
absorbance was recorded at 545 nm. Concen-
trationsweredeterminedbasedonastandard
curve prepared with sodium nitrite (0.2–5.0
nmol/sample). The sensitivity of the assay
was 0.5 M.
Immunoblot analysis. Cell lysates or lung
homogenates (30 g of protein per lane) were
subjected to SDS/polyacrylamide (10%) gel
electrophoresis and proteins were electro-
transferred to PVDV membrane in a buffer
containing 25 mM Tris, 192 mM glycine, pH
8.3, 20% methanol and 0.05% SDS. The en-
zyme protein was visualized using mouse
monoclonal antibody (specific for iNOS of
mouse, rat, human and dog) from
Transduction Laboratories (U.S.A.). Immuno-
detection was performed using Amplified
OPTI-4CNKit(Bio-Rad)accordingtotheman-
ufacturer’s protocol. As a positive control
lysates from peritoneal macrophages of mice
treated with BCG were used.
Protein assay. Protein concentration was
measured in macrophage lysates with Cooma-
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Spector (1978).
Statistics. Results are presented as mean
±S.E.M., with the number of experiments (N)
given in parentheses. The nonparametric
signed rank Mann-Whitney U test (Siegel,
1956) was used to evaluate significance of dif-
ferences (considered significant when H0
could be rejected at  > 0.05) between sam-
ples.
RESULTS
Cellular infiltration of alveolar space
Consistent with our previous results (Dzik et
al., 2000), guinea pig infection by T. spiralis
larvae was followed by a marked increase of
cell infiltration to the pulmonary alveolar
space starting on the 4th day and persisting
until 14th day after infection. Macrophages,
neutrophils, and eosinophils were signifi-
cantly accumulated on the 6th and 14th days
after infection (Fig. 1) but only an apparently
transient increase of lymphocyte number on
the 6th day was noted. Treatment of unin-
fected animals with CsA 2 days before and 4
days after placebo administration resulted in
an unexpected extensive accumulation of
macrophages, lymphocytes and eosinophils
(reflected also by total cell number) in pulmo-
nary alveolar space (Fig. 1A, C, D and E).
Treatment of T. spiralis-infected animals with
CsA resulted in significantly changed macro-
phage and lymphocyte infiltration observed 6
days after infection. CsA caused a further in-
crease of total leucocyte and macrophage
number with a simultaneous diminution of
lymphocyte infiltration (Fig. 1A, C and E),
and no change in the number of eosinophils
and neutrophils (Fig. 1 B and D) compared
with infected, non-treated animals. It should
be noted that on the 14th day after infection
no effect of CsA on cellular infiltration into al-
veolar space of infected animals was observed
(Fig. 1).
Superoxide anion production
Alveolar macrophages, recovered from
BALF on 6th day after infection, showed a
prominentO2
 production, about 3-fold higher
than control values (Table 1) but the differ-
ence became insignificant on the 14th day af-
ter infection. While CsA treatment doubled
superoxide anion production by infiltrating
macrophages of uninfected animals, it abol-
ished the stimulation ofO2
 production on the
6thdayand,toalesserextent,onthe14thday
after infection with T. spiralis (Table 1).
Nitric oxide production resulting from NOS
activity
NO synthesis was not stimulated over its ba-
sic rate in alveolar macrophages from T.
spiralis-infected animals on the 6th day after
infection. Moreover, on the 14th day after in-
fection NO production was even significantly
lowered (Table 1). CsA treatment of both con-
trol and T. spiralis-infected guinea pigs was
without any significant effect on NOS activity
in lysates of alveolar macrophages, with the
exception of the 14th day after infection,
when it appeared to prevent the above men-
tioned lowering of NO production (Table 1).
Treatment of guinea pigs in vivo with BCG
vaccine, a well recognized stimulus of iNOS
expression in rodents, did not increase nitric
oxide production (not shown).
Expression of iNOS protein in macrophages
and lungs
Immunoblot analysis of macrophage lysates
from uninfected, T. spiralis-infected, and
BCG-treated guinea pigs, probed with anti-
iNOS antibody (crossreacting with mouse,
rat, dog and human iNOS), demonstrated an
immunoreactiveproteinband(Fig.2).There-
active protein is located at the position corre-
sponding to that in the positive control
(lysates from peritoneal macrophages of
mouse stimulated with BCG) and is located at
the same position as the prestained molecular
Vol. 49 Cyclosporin A and guinea pig lung response to Trichinella spiralis infection 237massstandardof132kDa(Bio-Rad).Lysateof
peritoneal macrophages from non-stimulated
mouse, used as a negative control, did not
showtheiNOSband.CyclosporinAdidnotaf-
fect expression of iNOS in macrophages both
of uninfected and T. spiralis-infected guinea
pigs. Also injection of antibodies against
TGF-waswithouteffectoniNOSexpression.
Immunoblot analysis of lung homogenates
alsodemonstratedthepresenceofnitricoxide
synthase in lungs of both uninfected and T.
spiralis-infected guinea pigs (Fig. 3). In con-
trasttomacrophages,CsAtreatmentofeither
infected or uninfected animals suppressed ex-
pressionofiNOSinthelungs.TreatmentofT.
spiralis-infected guinea pigs with anti-TGF-
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Figure 1. Effect of CsA treatment on cellular infiltration of lung bronchoalveolar spaces of Trichinella
spiralis-infected guinea pig.
Differential cell counts of macrophages (A), neutrophils (B), lymphocytes (C), eosinophils (D) and total leucocytes
(E) recovered from BAL peformed in uninfected and T. spiralis-infected (6 and 14 days after infection) animals, ei-
ther non-treated (open bars) or CsA-treated (closed bars).
aSignificantly different from uninfected, non-treated ani-
mals.
bSignificantly different from infected, non-treated animals.antibodies increased (2–3-fold, as indicated
by densitometric estimation; not shown) the
expression of iNOS in the lungs.
Influence of CsA on concentration of NO
metabolites in BALF and lung homogenates
Concentration of NO metabolites (NO2
 +
NO3
 ) in BALF supernatant, but not in lung
homogenates, of T. spiralis-infected guinea
pigs was significantly increased on the 6th
day after infection. CsA treatment resulted in
a significant diminution of nitrites and ni-
trates concentration in BALF supernatant
from T. spiralis-infected animals. The pres-
ence of anti-TGF- antibodies in the blood of
T. spiralis-infected animals did not increase
significantly the level of NO metabolites. Nei-
ther CsA nor anti-TGF- antibodies affected
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Table 1. Effect of cyclosporin A on superoxide anion and nitric oxide production in cultured alveolar
macrophages from Trichinella spiralis-infected guinea pigs
Days after infection
O2
– production
(nmol/mg protein per h)
NOS activity
(nmol/mg protein per h)
Non-treated CsA-treated Non-treated CsA-treated
Uninfected 17.3 ± 3.2 (8) 34.9 ± 1.9 (5)
a 0.7 ± 0.2 (6) 1.3 ± 0.8 (4)
6 62.4 ± 12.6 (9)
a 30.8 ± 2.6 (5)
b 1.7 ± 0.5 (9) 0.9 ± 0.2 (3)
14 36.0 ± 12.4 (3) 24.8 ± 3.1 (4) 0.2 ± 0.0 (6)
a 1.7 ± 0.6 (5)
b
aSignificantly different (P 	 0.05) from uninfected, non-treated animals.
bSignificantly different (P 	 0.05) from infected,
non-treated animals.
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Figure 2. Expression of iNOS protein in guinea pig and mouse macrophage lysates.
Lane 1, molecular mass standards; lane 2, alveolar macrophages from uninfected, non-treated guinea pig; lane 3, al-
veolar macrophages isolated 6 days after T. spiralis infection of guinea pig; lane 4, alveolar macrophages isolated 6
days after T. spiralis infection and anti-TGF- antibody treatment (on the 3th and 5th days after infection) of guinea
pig; lane 5, alveolar macrophages from uninfected, CsA-treated guinea pig; lane 6, alveolar macrophages isolated 6
days after T. spiralis infection and CsA treatment of guinea pig; lane 7, alveolar macrophages isolated 14 days after
T. spiralis infection of guinea-pig; lane 8, alveolar macrophages isolated 14 days after T. spiralis infection and CsA
treatment of guinea pig; lane 9, alveolar macrophages from BCG-treated guinea pig; lane 10, peritoneal
macrophages from control mouse; lane 11, peritoneal macrophages from BCG-treated mouse.the nitrite and nitrate levels in lungs of both
infectedanduninfectedguineapigs(Table2).
DISCUSSION
In the earlier studies a significant increase
ofcellularinfiltrationintopulmonaryalveolar
space in the early period (4–14 days) after T.
spiralis infection, suggested that broncho-
alveolar leucocytes play a significant role in
lungresistanceagainstmigratinglarvae(Dzik
et al., 2000). Similar results were obtained by
Egwang et al. (1984) who studied cellular re-
sponses in rat lungs following primary and
secondary infection with Nippostrogylus brasi-
liensis, another parasite whose larvae migrate
via blood and lymphatics through the lungs.
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Figure 3. Expression of iNOS protein in guinea pig lungs.
Lane 1, molecular mass standards; lane 2, non-treated guinea pig lung homogenate; lane 3, CsA-treated guinea pig
lung homogenate; lane 4, T. spiralis-infected guinea pig lung homogenate; lanes 5 and 6, CsA-treated and
T. spiralis-infected guinea pig lung homogenate, prepared 6 and 14 days after infection, respectively; lane 7,
T. spiralis-infected and anti-TGF--treated guinea pig lung homogenate.
Table 2. Effect of cyclosporin A on (NO NO 23
 
-) concentration in bronchoalveolar lavage fluids
(BALF) and lung homogenates of guinea pigs infected with T. spiralis
(NO NO 23
  )
Treatment
BALF supernatants Lung homogenates
(µM) (nmol/g wet weight)
Uninfected animals
None 1.9 ± 0.4 (3) 62.8 ± 3.1 (3)
CsA 2.4 ± 0.1 (5) 67.1 ± 2.1 (4)
Infected animals (6th day after infection)
None 3.9 ± 0.6 (3)
a 78.0 ± 4.2 (3)
CsA 2.2 ± 0.1 (5)
b 58.3 ± 3.6 (4)
Anti-TGF- 3.1 ± 0.3 (4) 62.2 ± 6.3 (5)
aSignificanly different (P 	 0.05) from uninfected, non-treated animals.
bSignificanly different (P 	 0.05) from infected,
non-treated guinea pigs.As shown in the present paper, treatment
with CsA by itself significantly increased
macrophage, lymphocyte and eosinophil infil-
tration into alveolar space of uninfected ani-
mals (Fig. 1). Many studies reveal that CsA
may sometimes paradoxically enhance im-
mune responses and induce specific forms of
autoimmunity, depending on the dose, timing
of drug delivery and experimental model (for
a review see Prud’homme and Vanier, 1993).
To our knowledge there are no data concern-
ingtheeffectsofCsAoncellularinfiltrationin
the lungs. In other tissues increased accumu-
lation of macrophages and granulocytes after
CsA treatment has been reported (Dick et al.,
1997; Taskinen & Roytta, 2000). Most studies
were dealing with the effects of CsA on the an-
tigen-induced immunological response, ex-
pressed mainly by eosinophil infiltration, in-
duced in the lungs in vivo or in vitro.
Treatment with oral CsA affected the re-
sponse of guinea pigs to the parasite by mark-
edlyincreasingT.spiralis-inducedtotalcellac-
cumulationinalveolarspaceonthe6thdayaf-
ter infection (Fig. 1E). Polymorphonuclear
leucocyte infiltration in CsA-treated, T. spira-
lis-infected guinea pigs, was increased
non-significantly due to high individual varia-
tions (Fig. 1B, D). Similarly, Ceyhan et al.
(1998) observed increased total number of
BAL cells after inhalation of CsA by oval-
bumin-sensitized rats.
ApartfromabeneficialeffectofCsAonaller-
gen-induced bronchial eosinophilia in guinea
pigs in vivo (Lagente et al., 1994), no signifi-
cant effect on BALF eosinophil content was
found during hypersensitivity pneumonitis
caused by actinomycete Faeni rectivirgula in
mice(Denisetal.,1992)oracutecutaneousin-
flammation in guinea pigs (Teixeira et al.,
1996). According to Norris et al. (1992), CsA
treatment following sensitization did not re-
duce antigen-induced eosinophilia in guinea
pig lungs but abolished it when the drug was
given at the time of sensitization. A
pro-inflammatoryactionofCsAwasdescribed
also by Wang et al. (1993), who observed in-
creased eosinophil recruitment in the lungs of
mice with allergic bronchopulmonary asper-
gillosis after pretreatment with the drug.
It has to be pointed out that while CsA main-
tained significantly increased macrophage ac-
cumulation, it prevented lymphocyte infiltra-
tion induced by T. spiralis on the 6th day after
infection (Fig. 1A and C). Decreased lympho-
cyteinfiltrationwasalsodescribedinBALFof
mice with hypersensitivity pneumonitis
caused by F. rectivirgula in vivo (Denis et al.,
1992) and in sensitized rats with allergen in-
duced hyperresponsiveness (Elwood et al.,
1992). A decrease lymphocyte accumulation
by CsA has been proposed to be due to the
drug’s ability to suppress lymphokine produc-
tion and inhibit of leucocyte-endothelial inter-
actions (Issekutz, 1989; De Caterina et al.,
1995; Chapman & Mazzoni, 1994). The lack of
CsA effect on cellular infiltration of broncho-
alveolar space induced by T. spiralis on 14th
day after infection may be due to the limited
availability of the drug at this time interval
(Kahan, 1994).
While the ability of CsA to induce reactive
metabolites of oxygen has been extensively
studied, its mechanism is still unclear. It has
been shown that CsA toxicity in kidney, liver
and nervous system is accompanied by in-
creased both H2O2 production and lipid
peroxidation, and concominantly decreased
cellular level of reduced glutathione (Suley-
manlar et al., 1994; Wolf et al., 1994; Calo et
al., 2000). Stimulation of superoxide produc-
tion and significant prolongation of
ADP-stimulated superoxide production have
been observed in rat alveolar macrophages
treatedwithCsAinvitro(Formanetal.,1998).
Inaccord,alveolarmacrophagesofuninfected
guinea pigs responded to treatment of ani-
mals with CsA by stimulation of superoxide
anion production (Table 1). In unstimulated
cells CsA may influence the dephosphory-
lation processes accompanying activation of
NADPH oxidase, as okadaic acid, a protein
phosphatase 2A inhibitor, has been shown to
prolong the oxidase activation caused by
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nylalanine in human neutrophils (Lu et al.,
1992).
CsA treatment caused an attenuation of the
enhanced O2
 production by macrophages
from T. spiralis-infected animals (Table 1),
suggesting the signal for activation of macro-
phage NADPH oxidase to be inhibited by CsA.
A similar inhibitory effect of CsA was ob-
served by Chiara et al. (1989) in phorbol es-
ter-stimulated resident peritoneal mouse
macrophages.Withrespecttothelatter,ithas
been shown that CsA inhibits cytokine gene
expression in activated T lymphocytes and
macrophages (Thomson, 1992; Svensson et
al., 1995) by blocking calcineurin, a
Ca2+/calmodulin dependent serine/threonine
phosphatase (Liu et al., 1991).
NOS activity in cultured guinea pig alveolar
macrophages was not increased on the 6th
and decreased on 14th day after T. spiralis in-
fection. Following CsA treatment, the activity
was unchanged on 6th and 14th days after in-
fection, but on 14th day after infection it was
higher than in non-treated control (Table 1).
Hence, CsA treatment appears to prevent the
lowering of NOS activity, observed on 14th
day after T. spiralis infection. It is well estab-
lished that expression and activity of iNOS in
rodent macrophages is induced by LPS,
IFN-, TNF- or BCG (Morris & Billiar, 1994;
Zhang & McMurray, 1998), although species
differences have been reported (Salter et al.
1991; Jesch et al., 1997). Guinea-pig alveolar
macrophagesdidnotproduceNOafterinvitro
stimulation with hrIFN- and/or LPS or BCG
(Zhang & McMurray, 1998). Comparative
studies revealed that Legionella pneumophilia
infection caused induction of NO production
in mouse, but not in guinea pig, peritoneal
macrophages (Rajagopalan-Levassieur et al.,
1996). However, endothelial and/or epithelial
cellsofairways(Rochelleetal.,1998;Nijkamp
et al., 1993) are a potential source of NO me-
tabolites recovered in BALF supernatant and
might be responsible for the observed in-
crease of nitrate and nitrite accumulation (Ta-
ble 2). Since endothelial cells are in intimate
contact with larvae during their intravascular
lung migration phase, it is tempting to specu-
late that they may play role in a defense mech-
anisms in vivo (cf. Oswald et al., 1994). How-
ever, this effect was attenuated by CsA treat-
ment, although CsA did not effect NO metabo-
lite production in uninfected animals (Ta-
ble 2), which argues against the involvement
of endothelial NOS known to be stimulated by
CsAtreatment(Navarro-Antolinetal.,2000).
Immunoblot analysis with a specific anti-
iNOS monoclonal antibody, of alveolar
macrophage lysates from control and
T. spiralis-infected guinea pigs, showed the
presence of an immunoreactive protein, iden-
tified additionally as iNOS by its molecular
mass and colocalization with a positive con-
trol(BCG-stimulatedmouseperitonealmacro-
phages) (Fig. 2). Guinea pig macrophage
iNOS expression was not influenced by in vivo
treatment with CsA or anti-TGF- antibody
(Fig. 2). In contrast, CsA has been demon-
strated to inhibit iNOS expression in many
cell lines, including rat aortic smooth muscle
cells (Muramo et al., 1995), transformed
macrophage cell line J774 (Burkart et al.,
1992), rat renal mesangial cells (Kunz et al.,
1995) and murine macrophage cell line RAW
264.7 (Attur et al., 2000). Moreover, TGF- is
known to destabilize iNOS mRNA and de-
crease its translation in inflammatory mouse
macrophages, as well as to reduce the level of
the iNOS protein in mouse peritoneal
macrophages (Vodovotz, 1997). So, neutral-
izationofthiscytokinewithantibodieswasex-
pected to augment the expression of iNOS in
macrophages, which was not the case. Simi-
larly, treatment with anti-TGF-1 did not
raise the low NO production of human mono-
cytes in response to cytokines (Weinberg et
al., 1995). The lack of influence of CsA or
anti-TGF- antibody on iNOS expression in al-
veolar macrophages, isolated from both unin-
fectedandT.spiralis-infectedguineapigs,sug-
gests that iNOS is constitutively present in
guinea pig macrophages and is regulated by
242 J.M. Dzik and others 2002mechanisms different from those found so far
in other rodent’s macrophages.
As it was mentioned above, lungs contains
NOS derived from endothelial and/or epithe-
lial cells of airways and from interstitial
macrophages. The latter may explain the pat-
ternoftheiNOSexpressioninguineapiglung
homogenates being different from that in al-
veolar macrophages (Fig. 3). The available
data indicate NOS isolated from guinea pig
lung to be distinct from the common iNOS
isoform, as it is calcium-dependent and insen-
sitive to in vivo treatment of the animals with
LPS (Salter et al., 1991; Shirato et al., 1998).
Expression of iNOS in lungs of control and T.
spiralis-infected guinea pigs was abolished by
CsA treatment, but present, and even en-
hanced, in homogenates from T. spiralis-in-
fectedandanti-TGF-treatedanimals(Fig.3).
The sensitivity of guinea pig lung iNOS ex-
pression to CsA observed in our studies may
suggest a requirement for calcineurin-media-
tedNF
Bactivation(Nathan&Xie,1994).Re-
cently, Bian et al. (2001) described the iNOS
protein to be expressed in control, uninfected
mouse lung, the expression being lowered by
T. spiralis infection. Expression of iNOS was
observed also in lung (and alveolar macro-
phages, see above) of uninfected guinea pigs
but it was not lowered by the infection (Figs.
2, 3).
The present results indicate that iNOS ex-
pression in guinea pig lungs is not correlated
with NO metabolite production (Table 2,
Fig. 3), as the effects of CsA (abolishment)
and anti-TGF- antibodies (enhancement) on
iNOS expression did not influence NO metab-
olite production accordingly (by either cancel-
ing or increasing this production). The latter
points to the participation of other NOS
isoforms.
In conclusion, it is shown that CsA by itself
has a pro-inflammatory effect, promoting leu-
cocyte accumulation and macrophage super-
oxide production in the lungs of guinea pigs,
whichmayhavearelevancetothesituationin
patients undergoing CsA therapy. However,
CsA treatment significantly attenuates the
parasite-induced response in the lungs of
guinea pigs, allowing one to speculate that T.
spiralis-dependent immunological response is
dependent on lymphocyte T function.
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